Group presentation Gedeon Homos Laboratories Medical - Laboratories Vihcorp - Pharmaceutical Care Center ips - green lighting

1. CORPORATE OVERVIEW
• COLOMBIA
• A LEADER COMPANY HAS BORN

2. WHO WE ARE
 We are a dynamic and efficient company which expertise is based on a
knowledgeable and resourceful team that works locally as well as
internationally.
 Our company´s mission is to bring to our market, new advances and
technologies which represent evolution and new hopes for the community of
patients and for the pharmaceutical market .

3. OUR GROUP OF ENTERPRISES
 HOMOS MEDICAL LABORATORY : Strategic
partner in defence of the label. Representation and
distribution of oncology, HIV and hematologic
products.
 VHICORP LABORATORIES: Broker
pharmacist. Strategic partner in support of your
development and growth. Representation and
distribution of critical care medicines and
specialised products for hospitals.
 CAFI IPS: Pharmaceutical Basic Healthcare Centre
where HIV patients receive primary aid.
 BIOCORP: Natural alternative to your health. Free
medicine prescription (OTC)

4. COMPANY PROFILE
 GIDEON GROUP was founded as a result of the demand
of our own set of costumers.
 It was created because of the need to consolidate a group
of companies which goal is to provide special attention to
our costumers and to the entire pharmaceutical market
with high standards and quality products and services.
 GIDEON GROUP is a group of companies which has been
in the market for over eight years.
 Today we have transformed our model of business within
the group reflecting on the demand and the best target of
potential costumers.
 The integration of these businesses pretends to aid and
assist the different needs of our clients such as
hemophilia, HIV, oncology, orphan drugs, metabolic
diseases, among others.

5. OUR HOLDING
 Regulatory affairs  Sales to institutions  Attention and  Importer
and drugstores  Market Research
support Integral treatment
 Supply drugs and  Market
 Pharmacovigilance  Patient Home Care
medical devices to development
 Marketing  Management Disease  Owner of
management HMO´s patients supported by the
 Supply and Licensing and
 Marketing research program Brands Projects
distribute products
 Promotional  CRM program to
to patient in ICU
activities  Supply products to
follow up patients in:
 Medical Direction private patients  Dosage
 Call reps force in  Home delivery  Frequency
main cities program  Refills

6. CORPORATE VALUES
CONTINUE
EFFICIENCY
GROWING
QUALITY COMMUNITY
SERVICE
CONFIDENCE/
TRUST CREATIVITY
INNOVATION

7. HOLDING TURN OVER
 (*)Established 2006
 Capital 100 % Colombian
 Turn Over $ Usd 1.000.000
 Market Share 1,2 Values 2,3 % Units (I.M.S. ) Distribution
Channels
 Sales Mix 80 % Market & distribution Local products
20 % Own Operation
 Employees 11 Administrative , 23 Sales and Line Force

8. HOLDING SALES EVOLUTION
3000000
2500000
2000000
HOMOS MEDICAL
1500000 VIHCORP
1000000 CAFI IPS
500000
0
2006 2007 2008 2009
US DOLLARS

9. OUR LINES OF THERAPIES
PARENTERAL NUTRITION, NUTRITION ENTERAL
AND BIOLOGICAL LINE
CRITICAL CARE
ONCO- VIH LINE PRODUCTS
TRANSPLANTS AND HORMONAL LINE

10. MARKET DISTRIBUTION CAPABILITY
Distribution Main sales Accounts Market coverage Number of
Channel approach Number annual
invoices
served
Direct Sales Specialist 162 100% Oncology - arv- 4,282
IPS Pharmacy blood.
74% distributors
hospital
Distributors Purchase 195 •95% of dealers 2,873
manager
Hospitals Tender 18 •100% of high 446
complexity hospitals
•10% of level 1-2
Direct Sales Tender 4 35% of patients with 129
EPS Recruitment catastrophic
diseases

11. MARKETING & DIRECTION STAFF
BOARD OF
DIRECTORS
B.DEVELOPMENT MEDICAL HOLDING SALES NATIONAL ADMINISTRATIVE
DIRECTOR DIRECTOR MANAGER MANAGER
KEY ACCOUNT KEY ACCOUNT KEY ACCOUNT
ONCO- ARV LINE HOSPITAL CRITICAL CARE
MARKETING TENDER´S REP.
COORDINATOR K.A.
REPS. TEAM REPS. TEA REPS. TEA
HOMOS MEDICAL VHICORP LAB. VHICORP LAB.
•Bogota(2) •Bogota(2) •Bogota(2)
•Cali(1) •Cali(2) •Cali(1)
•Medellin(1) •Medellin(2) •Medellin(2)
•Costa (2) •Costa (4) •Costa (2)

12. STRATEGIC PARTNER IN DEFENCE OF THE LABEL.